# IL-18 production is required for the generation of a Th1 response during experimental chromoblastomycosis

**Authors:** Lucas Golçalves Ferreira, Sandro Rogério de Almeida, Divakar Sharma, Divakar Sharma, Divakar Sharma

PMC · DOI: 10.1371/journal.pone.0322127 · PLOS One · 2025-05-02

## TL;DR

The study shows that IL-18 is essential for triggering a Th1 immune response to fight chromoblastomycosis, a chronic fungal infection.

## Contribution

The study identifies IL-18 as a key mediator in Th1 cell activation during chromoblastomycosis.

## Key findings

- IL-18 is produced via the NLRP3 inflammasome in response to F. pedrosoi.
- IL-18 promotes Th1 cell activation and reduces fungal burden in chromoblastomycosis.
- Th1 responses are critical for protection against this chronic fungal infection.

## Abstract

Chromoblastomycosis is a chronic fungal infection characterized by the formation of granulomatous lesions in the skin and subcutaneous tissues that begins after inoculation trauma. The disease is more frequently observed in tropical countries such as Brazil. Important studies have been shown a predominantly cell-mediated immune response during chromoblastomycosis. Results from our laboratory showed that Th1 responses are essential to induce protection during chromoblastomycosis. IL-18 is primarily produced by macrophages and is known to induce the production of IFNγ, a cytokine associated with Th1 cell activation. Once produced, IL-18 acts to promote Th1 cell differentiation and activation. Th1 cells, in turn, secrete cytokines such as IFNγ, which are critical for the elimination of intracellular pathogens, including fungi. IFNγ enhances the fungicidal activity of macrophages, promotes the development of antifungal effector mechanisms, and contributes to the containment of fungal growth. Our results indicate that F. pedrosoi is sensed by the NLRP3 inflammasome, which induces caspase-1 activation and production of IL-18. Moreover, IL-18 plays a crucial role in activating Th1 cells and controlling fungal loads during chromoblastomycosis. Further research into the mechanisms underlying IL-18-mediated immunity may lead to the development of novel therapeutic approaches for the treatment of this chronic fungal infection.

## Linked entities

- **Genes:** NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], Caspase1 (caspase-1) [NCBI Gene 692604]
- **Proteins:** IL18 (interleukin 18), IFNG (interferon gamma)
- **Diseases:** chromoblastomycosis (MONDO:0015908)

## Full-text entities

- **Diseases:** fungal (MESH:D009181), Chromoblastomycosis (MESH:D002862), trauma (MESH:D014947), granulomatous (MESH:D013968)
- **Species:** Fonsecaea pedrosoi (species) [taxon 40355]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12047800/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12047800/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12047800/full.md

---
Source: https://tomesphere.com/paper/PMC12047800